{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:36:47Z","timestamp":1760060207523,"version":"build-2065373602"},"reference-count":81,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006578","name":"Chi Mei Medical Center","doi-asserted-by":"publisher","award":["111CM-TMU-03","111CM-TMU-03","NSTC 113-2314-B-384-003","NSTC 114-2923-B-038-001-MY3","NSTC 114-2320-B-038-044"],"award-info":[{"award-number":["111CM-TMU-03","111CM-TMU-03","NSTC 113-2314-B-384-003","NSTC 114-2923-B-038-001-MY3","NSTC 114-2320-B-038-044"]}],"id":[{"id":"10.13039\/501100006578","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006578","name":"Taipei Medical University","doi-asserted-by":"publisher","award":["111CM-TMU-03","111CM-TMU-03","NSTC 113-2314-B-384-003","NSTC 114-2923-B-038-001-MY3","NSTC 114-2320-B-038-044"],"award-info":[{"award-number":["111CM-TMU-03","111CM-TMU-03","NSTC 113-2314-B-384-003","NSTC 114-2923-B-038-001-MY3","NSTC 114-2320-B-038-044"]}],"id":[{"id":"10.13039\/501100006578","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"National Science and Technology Council (NSTC) of Taiwan","doi-asserted-by":"publisher","award":["111CM-TMU-03","111CM-TMU-03","NSTC 113-2314-B-384-003","NSTC 114-2923-B-038-001-MY3","NSTC 114-2320-B-038-044"],"award-info":[{"award-number":["111CM-TMU-03","111CM-TMU-03","NSTC 113-2314-B-384-003","NSTC 114-2923-B-038-001-MY3","NSTC 114-2320-B-038-044"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>The emergence of SARS-CoV-2 variants highlights the urgent need for novel therapeutic strategies, particularly entry inhibitors that could efficiently prevent viral infection. Medicinal herbs and herbal combination formulas have long been recognized for their effects in treating infectious diseases and their antiviral properties, thus providing abundant resources for the discovery of antiviral candidates. While many candidates have been suggested to have antiviral activity against SARS-CoV-2 infection, few have been validated for their mechanisms, including possible effects on viral entry. This study aimed to identify SARS-CoV-2 entry inhibitors from medicinal herbs and herbal formulas that are known for heat-clearing and detoxifying properties and\/or antiviral activities. A SARS-CoV-2 pseudoparticle (SARS-CoV-2pp) system was used to assess mechanism-specific entry inhibition. Our results showed that the methanol extract of Anemarrhena asphodeloides rhizome, as well as the water extracts of Cimicifuga foetida rhizome, Xiao Chai Hu Tang (XCHT), and Sheng Ma Ge Gen Tang (SMGGT), have substantial inhibitory effects on the entry of SARS-CoV-2pps into host cells. Given the observation that Cimicifuga foetida exhibited the most potent inhibition and is a constituent of SMGGT, we further investigated the major compounds of the herb and identified caffeic acid as a bioactive component for blocking SARS-CoV-2pp entry. Entry inhibition of Cimicifuga foetida and caffeic acid was validated on both wild-type and the currently dominant JN.1 strain SARS-CoV-2pp systems. Moreover, caffeic acid was able to both inactivate the pseudoparticles and prevent their entry into pretreated host cells. The results support the traditional use of these herbal medicines and underscore their potential as valuable resources for identifying active compounds and developing therapeutic entry inhibitors for the management of COVID-19.<\/jats:p>","DOI":"10.3390\/v17081086","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T15:56:16Z","timestamp":1754409376000},"page":"1086","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Screening of Medicinal Herbs Identifies Cimicifuga foetida and Its Bioactive Component Caffeic Acid as SARS-CoV-2 Entry Inhibitors"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5074-1785","authenticated-orcid":false,"given":"Ching-Hsuan","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Microbiology and Immunology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan"},{"name":"Department of Diagnostic Imaging, Chi Mei Medical Center, Tainan 710, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8704-0739","authenticated-orcid":false,"given":"Yu-Ting","family":"Kuo","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Imaging, Chi Mei Medical Center, Tainan 710, Taiwan"},{"name":"Institute of Precision Medicine, College of Medicine, National Sun Yat-sen University, Kaohsiung 804, Taiwan"},{"name":"Department of Radiology, School and College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chien-Ju","family":"Lin","sequence":"additional","affiliation":[{"name":"School of Pharmacy, College of Pharmacy, Kaohsiung Medical University, Kaohsiung 807, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng-Lin","family":"Yen","sequence":"additional","affiliation":[{"name":"Department of Fragrance and Cosmetic Science, College of Pharmacy, Kaohsiung Medical University, Kaohsiung 807, Taiwan"},{"name":"Drug Development and Value Creation Research Center, Kaohsiung Medical University, Kaohsiung 807, Taiwan"},{"name":"Department of Medical Research, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Jing","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Nutritional Health, Chia-Nan University of Pharmacy and Science, Tainan 717, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7374-7234","authenticated-orcid":false,"given":"Liang-Tzung","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan"},{"name":"Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei 110, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,5]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2025, February 10). Coronavirus Disease (COVID-19) Epidemiological Updates and Monthly Operational Updates. Available online: https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/situation-reports."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1093\/cid\/ciab079","article-title":"The impact of vaccination on COVID-19 outbreaks in the United States","volume":"73","author":"Moghadas","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_3","first-page":"162","article-title":"SARS-CoV-2 variant biology: Immune escape, transmission and fitness","volume":"21","author":"Carabelli","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S2213-2600(23)00015-2","article-title":"Long-term effectiveness of COVID-19 vaccines against infections, hospitalisations, and mortality in adults: Findings from a rapid living systematic evidence synthesis and meta-analysis up to December, 2022","volume":"11","author":"Wu","year":"2023","journal-title":"Lancet Respir. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/s41591-023-02219-5","article-title":"Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population","volume":"29","author":"Lau","year":"2023","journal-title":"Nat. Med."},{"key":"ref_6","unstructured":"U.S. Food and Drug Administration (2025, June 06). FDA Considerations and Recommendations for the 2025\u20132026 Formula of COVID-19 Vaccines in the United States, Available online: https:\/\/www.fda.gov\/media\/186594\/download."},{"key":"ref_7","unstructured":"U.S. Food and Drug Administration (2025, June 06). COVID-19 Vaccines (2025\u20132026 Formula) for Use in the United States Beginning in Fall 2025, Available online: https:\/\/www.fda.gov\/vaccines-blood-biologics\/industry-biologics\/covid-19-vaccines-2025-2026-formula-use-united-states-beginning-fall-2025."},{"key":"ref_8","unstructured":"U.S. Food and Drug Administration (2025, February 11). Coronavirus (COVID-19)|Drugs, Available online: https:\/\/www.fda.gov\/drugs\/emergency-preparedness-drugs\/coronavirus-covid-19-drugs."},{"key":"ref_9","unstructured":"Infectious Diseases Society of America (IDSA) (2024, February 11). IDSA Guidelines on the Treatment and Management of Patients with COVID-19. Available online: https:\/\/www.idsociety.org\/COVID19guidelines."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Hoffmann, M., Kleine-Weber, H., Schroeder, S., Kruger, N., Herrler, T., Erichsen, S., Schiergens, T.S., Herrler, G., Wu, N.H., and Nitsche, A. (2020). SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell, 181.","DOI":"10.1016\/j.cell.2020.02.052"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1126\/science.abd2985","article-title":"Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity","volume":"370","author":"Ojha","year":"2020","journal-title":"Science"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41392-020-00426-x","article-title":"CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells","volume":"5","author":"Wang","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Carlos, A.J., Ha, D.P., Yeh, D.W., Van Krieken, R., Tseng, C.C., Zhang, P., Gill, P., Machida, K., and Lee, A.S. (2021). The chaperone GRP78 is a host auxiliary factor for SARS-CoV-2 and GRP78 depleting antibody blocks viral entry and infection. J. Biol. Chem., 296.","DOI":"10.1016\/j.jbc.2021.100759"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"11727","DOI":"10.1073\/pnas.2003138117","article-title":"Cell entry mechanisms of SARS-CoV-2","volume":"117","author":"Shang","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Bayati, A., Kumar, R., Francis, V., and McPherson, P.S. (2021). SARS-CoV-2 infects cells after viral entry via clathrin-mediated endocytosis. J. Biol. Chem., 296.","DOI":"10.1016\/j.jbc.2021.100306"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/s41392-021-00558-8","article-title":"Cathepsin L plays a key role in SARS-CoV-2 infection in humans and humanized mice and is a promising target for new drug development","volume":"6","author":"Zhao","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41579-020-00468-6","article-title":"Coronavirus biology and replication: Implications for SARS-CoV-2","volume":"19","author":"Kratzel","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Takayama, S., Namiki, T., Odaguchi, H., Arita, R., Hisanaga, A., Mitani, K., and Ito, T. (2021). Prevention and Recovery of COVID-19 Patients with Kampo Medicine: Review of Case Reports and Ongoing Clinical Trials. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.656246"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s40001-022-00818-5","article-title":"Traditional herbs against COVID-19: Back to old weapons to combat the new pandemic","volume":"27","author":"Elekhnawy","year":"2022","journal-title":"Eur. J. Med. Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jtcme.2020.05.004","article-title":"Dietary therapy and herbal medicine for COVID-19 prevention: A review and perspective","volume":"10","author":"Panyod","year":"2020","journal-title":"J. Tradit. Complement. Med."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Al-Jamal, H., Idriss, S., Roufayel, R., Abi Khattar, Z., Fajloun, Z., and Sabatier, J.M. (2024). Treating COVID-19 with Medicinal Plants: Is It Even Conceivable? A Comprehensive Review. Viruses, 16.","DOI":"10.3390\/v16030320"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Belem, W.F., Liu, C.H., Hu, Y.T., Burnouf, T., and Lin, L.T. (2022). Validation of Viral Inactivation Protocols for Therapeutic Blood Products against Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). Viruses, 14.","DOI":"10.3390\/v14112419"},{"key":"ref_23","unstructured":"Taiwan Herbal Pharmacopeia 3rd Ed. Committee (2019). Taiwan Herbal Pharmacopeia, English Version."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.antiviral.2015.04.003","article-title":"Limonium sinense and gallic acid suppress hepatitis C virus infection by blocking early viral entry","volume":"118","author":"Hsu","year":"2015","journal-title":"Antiviral Res."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Hung, T.C., Jassey, A., Lin, C.J., Liu, C.H., Lin, C.C., Yen, M.H., and Lin, L.T. (2018). Methanolic Extract of Rhizoma coptidis Inhibits the Early Viral Entry Steps of Hepatitis C Virus Infection. Viruses, 10.","DOI":"10.3390\/v10120669"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.foodchem.2007.10.077","article-title":"Concordance between antioxidant activities and flavonol contents in different extracts and fractions of Cuscuta chinensis","volume":"108","author":"Yen","year":"2008","journal-title":"Food Chem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4103\/2225-4110.124335","article-title":"Antiviral natural products and herbal medicines","volume":"4","author":"Lin","year":"2014","journal-title":"J. Tradit. Complement. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.antiviral.2005.02.007","article-title":"Identification of natural compounds with antiviral activities against SARS-associated coronavirus","volume":"67","author":"Li","year":"2005","journal-title":"Antivir. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.antiviral.2005.07.002","article-title":"Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds","volume":"68","author":"Lin","year":"2005","journal-title":"Antivir. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jep.2008.03.018","article-title":"Immunomodulatory and anti-SARS activities of Houttuynia cordata","volume":"118","author":"Lau","year":"2008","journal-title":"J. Ethnopharmacol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Tsai, K.C., Huang, Y.C., Liaw, C.C., Tsai, C.I., Chiou, C.T., Lin, C.J., Wei, W.C., Lin, S.J., Tseng, Y.H., and Yeh, K.M. (2021). A traditional Chinese medicine formula NRICM101 to target COVID-19 through multiple pathways: A bedside-to-bench study. Biomed. Pharmacother., 133.","DOI":"10.1016\/j.biopha.2020.111037"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/s41401-020-0483-6","article-title":"Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients","volume":"41","author":"Su","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"104761","DOI":"10.1016\/j.phrs.2020.104761","article-title":"Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2)","volume":"156","author":"Li","year":"2020","journal-title":"Pharmacol. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.antiviral.2016.03.012","article-title":"Activity-based and fraction-guided analysis of Phyllanthus urinaria identifies loliolide as a potent inhibitor of hepatitis C virus entry","volume":"130","author":"Chung","year":"2016","journal-title":"Antiviral. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jhep.2014.10.040","article-title":"Saikosaponin b2 is a naturally occurring terpenoid that efficiently inhibits hepatitis C virus entry","volume":"62","author":"Lin","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1039\/C8AY01942H","article-title":"Determination of three phenolic acids in Cimicifugae rhizoma by capillary electrophoresis with a graphene\u2013phenolic resin composite electrode","volume":"11","author":"Mao","year":"2019","journal-title":"Anal. Methods"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jep.2017.07.040","article-title":"Traditional uses, phytochemistry, pharmacology and toxicology of the genus Cimicifuga: A review","volume":"209","author":"Guo","year":"2017","journal-title":"J. Ethnopharmacol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00232-020-00136-z","article-title":"Entry Inhibitors: Efficient Means to Block Viral Infection","volume":"253","author":"Pattnaik","year":"2020","journal-title":"J. Membr. Biol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Kuo, Y.T., Liu, C.H., Corona, A., Fanunza, E., Tramontano, E., and Lin, L.T. (2021). The Methanolic Extract of Perilla frutescens Robustly Restricts Ebola Virus Glycoprotein-Mediated Entry. Viruses, 13.","DOI":"10.3390\/v13091793"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Kuo, Y.T., Liu, C.H., Li, J.W., Lin, C.J., Jassey, A., Wu, H.N., Perng, G.C., Yen, M.H., and Lin, L.T. (2020). Identification of the phytobioactive Polygonum cuspidatum as an antiviral source for restricting dengue virus entry. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-71849-3"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1002\/jssc.201200026","article-title":"Simultaneous determination of nine components in Anemarrhena asphodeloides by liquid chromatography-tandem mass spectrometry combined with chemometric techniques","volume":"35","author":"Sun","year":"2012","journal-title":"J. Sep. Sci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jpba.2013.12.040","article-title":"A metabolomic approach to determine the geographical origins of Anemarrhena asphodeloides by using UPLC-QTOF MS","volume":"92","author":"Kim","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jpba.2017.06.039","article-title":"Comparison of alpha-glucosidase inhibitory effect and bioactive constituents of Anemarrhenae Rhizoma and Fibrous Roots","volume":"145","author":"Nian","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.chroma.2014.09.064","article-title":"Folding fan mode counter-current chromatography offers fast blind screening for drug discovery. Case study: Finding anti-enterovirus 71 agents from Anemarrhena asphodeloides","volume":"1368","author":"Liu","year":"2014","journal-title":"J. Chromatogr. A"},{"key":"ref_46","first-page":"1062","article-title":"Anti-respiratory syncytial virus (RSV) activity of timosaponin A-III from the rhizomes of Anemarrhena asphodeloides","volume":"5","author":"Youn","year":"2011","journal-title":"J. Med. Plants Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1002\/cbdv.200790181","article-title":"Identification of nyasol and structurally related compounds as the active principles from Anemarrhena asphodeloides against respiratory syncytial virus (RSV)","volume":"4","author":"Bae","year":"2007","journal-title":"Chem. Biodivers."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Mieres-Castro, D., and Mora-Poblete, F. (2023). Saponins: Research Progress and Their Potential Role in the Post-COVID-19 Pandemic Era. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15020348"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"112","DOI":"10.4103\/2221-1691.372284","article-title":"Antiviral activity of mangiferin from the rhizome of Anemarrhena asphodeloides against herpes simplex virus type 1","volume":"13","author":"Wang","year":"2023","journal-title":"Asian Pac. J. Trop. Biomed."},{"key":"ref_50","first-page":"160","article-title":"Antiviral effect of mangiferin and isomangiferin on herpes simplex virus","volume":"103","author":"Zheng","year":"1990","journal-title":"Chin. Med. J."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"4264","DOI":"10.3390\/molecules16054264","article-title":"Mangiferin, an anti-HIV-1 agent targeting protease and effective against resistant strains","volume":"16","author":"Wang","year":"2011","journal-title":"Molecules"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/tkm2.1258","article-title":"Kakkonto, shosaikoto, Platycodon grandiflorum root, and gypsum (a Japanese original combination drug known as saikatsugekito): Pharmacological review of its activity against viral infections and respiratory inflammatory conditions and a discussion of its applications to COVID-19","volume":"7","author":"Arita","year":"2020","journal-title":"Tradit. Kampo Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1142\/S0192415X07004862","article-title":"Sho-saiko-to (Xiao-Chai-Hu-Tang) and crude saikosaponins inhibit hepatitis B virus in a stable HBV-producing cell line","volume":"35","author":"Chang","year":"2007","journal-title":"Am. J. Chin. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.intimp.2006.01.011","article-title":"Xiao chai hu tang inhibits CVB1 virus infection of CCFS-1 cells through the induction of Type I interferon expression","volume":"6","author":"Cheng","year":"2006","journal-title":"Int. Immunopharmacol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1142\/S0192415X97000123","article-title":"Inhibition effect of shengma-gegen-tang on measles virus in Vero cells and human peripheral blood mononuclear cells","volume":"25","author":"Huang","year":"1997","journal-title":"Am. J. Chin. Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jep.2008.06.004","article-title":"Sheng-Ma-Ge-Gen-Tang inhibited Enterovirus 71 infection in human foreskin fibroblast cell line","volume":"119","author":"Chang","year":"2008","journal-title":"J. Ethnopharmacol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jep.2011.03.058","article-title":"Sheng-Ma-Ge-Gen-Tang (Shoma-kakkon-to) inhibited cytopathic effect of human respiratory syncytial virus in cell lines of human respiratory tract","volume":"135","author":"Wang","year":"2011","journal-title":"J. Ethnopharmacol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jgr.2015.09.002","article-title":"Ginseng, the natural effectual antiviral: Protective effects of Korean Red Ginseng against viral infection","volume":"40","author":"Im","year":"2016","journal-title":"J. Ginseng Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jgr.2024.12.004","article-title":"Antiviral potential of ginseng: Targeting human pathogenic viruses with compounds derived from ginseng","volume":"49","author":"Huo","year":"2024","journal-title":"J. Ginseng Res."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Huan, C., Xu, Y., Zhang, W., Guo, T., Pan, H., and Gao, S. (2021). Research Progress on the Antiviral Activity of Glycyrrhizin and its Derivatives in Liquorice. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.680674"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"112671","DOI":"10.1016\/j.jep.2020.112671","article-title":"Anti-influenza virus phytochemicals from Radix Paeoniae Alba and characterization of their neuraminidase inhibitory activities","volume":"253","author":"Zhang","year":"2020","journal-title":"J. Ethnopharmacol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jep.2012.10.043","article-title":"Fresh ginger (Zingiber officinale) has anti-viral activity against human respiratory syncytial virus in human respiratory tract cell lines","volume":"145","author":"Chang","year":"2013","journal-title":"J. Ethnopharmacol."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Lin, C.H., Chang, H.J., Lin, M.W., Yang, X.R., Lee, C.H., and Lin, C.S. (2024). Inhibitory Efficacy of Main Components of Scutellaria baicalensis on the Interaction between Spike Protein of SARS-CoV-2 and Human Angiotensin-Converting Enzyme II. Int. J. Mol. Sci., 25.","DOI":"10.20944\/preprints202401.2061.v1"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1142\/S0192415X12500127","article-title":"Cimicifuga foetida L. Inhibited Human Respiratory Syncytial Virus in HEp-2 and A549 Cell Lines","volume":"40","author":"Wang","year":"2012","journal-title":"Am. J. Chin. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1142\/S0192415X12500760","article-title":"Antiviral effect of cimicifugin from Cimicifuga foetida against human respiratory syncytial virus","volume":"40","author":"Wang","year":"2012","journal-title":"Am. J. Chin. Med."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Antonopoulou, I., Sapountzaki, E., Rova, U., and Christakopoulos, P. (2021). Ferulic Acid From Plant Biomass: A Phytochemical with Promising Antiviral Properties. Front. Nutr., 8.","DOI":"10.3389\/fnut.2021.777576"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Pasquereau, S., Galais, M., Bellefroid, M., Pachon Angona, I., Morot-Bizot, S., Ismaili, L., Van Lint, C., and Herbein, G. (2022). Ferulic acid derivatives block coronaviruses HCoV-229E and SARS-CoV-2 replication in vitro. Sci. Rep., 12.","DOI":"10.1038\/s41598-022-24682-9"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1007\/s00044-023-03134-7","article-title":"Synthesis of indole-based ferulic acid derivatives and in vitro evaluation of antiviral activity against SARS-CoV-2","volume":"32","author":"Verzola","year":"2023","journal-title":"Med. Chem. Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2217\/fvl-2020-0079","article-title":"Virtual Screening of Immunomodulatory Medicinal Compounds as Promising anti-SARS-CoV-2 Inhibitors","volume":"15","author":"Salman","year":"2020","journal-title":"Future Virol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"104451","DOI":"10.1016\/j.meegid.2020.104451","article-title":"Identification of potential inhibitors against SARS-CoV-2 by targeting proteins responsible for envelope formation and virion assembly using docking based virtual screening, and pharmacokinetics approaches","volume":"84","author":"Bhowmik","year":"2020","journal-title":"Infect. Genet. Evol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.3892\/ijmm.2014.1859","article-title":"Inhibition by caffeic acid of the influenza A virus multiplication in vitro","volume":"34","author":"Utsunomiya","year":"2014","journal-title":"Int. J. Mol. Med."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1248\/bpb.b18-00970","article-title":"Inhibition Mechanisms of Hepatitis C Virus Infection by Caffeic Acid and Tannic Acid","volume":"42","author":"Shirasago","year":"2019","journal-title":"Biol. Pharm. Bull."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jiac.2020.10.015","article-title":"Structural basis of antiviral activity of caffeic acid against severe fever with thrombocytopenia syndrome virus","volume":"27","author":"Ogawa","year":"2021","journal-title":"J. Infect. Chemother."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Saivish, M.V., Pacca, C.C., da Costa, V.G., de Lima Menezes, G., da Silva, R.A., Nebo, L., da Silva, G.C.D., de Aguiar Milhim, B.H.G., da Silva Teixeira, I., and Henrique, T. (2023). Caffeic Acid Has Antiviral Activity against Ilheus Virus In Vitro. Viruses, 15.","DOI":"10.3390\/v15020494"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"197767","DOI":"10.1016\/j.virusres.2019.197767","article-title":"Antiviral activity of Sambucus FormosanaNakai ethanol extract and related phenolic acid constituents against human coronavirus NL63","volume":"273","author":"Weng","year":"2019","journal-title":"Virus Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"199078","DOI":"10.1016\/j.virusres.2023.199078","article-title":"Molecular mechanisms of human coronavirus NL63 infection and replication","volume":"327","author":"Castillo","year":"2023","journal-title":"Virus Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"153310","DOI":"10.1016\/j.phymed.2020.153310","article-title":"Caffeic acid derivatives (CAFDs) as inhibitors of SARS-CoV-2: CAFDs-based functional foods as a potential alternative approach to combat COVID-19","volume":"85","author":"Adem","year":"2021","journal-title":"Phytomedicine"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"530","DOI":"10.3906\/biy-2104-5","article-title":"Targeting CoV-2 spike RBD and ACE-2 interaction with flavonoids of Anatolian propolis by in silico and in vitro studies in terms of possible COVID-19 therapeutics","volume":"45","author":"Guler","year":"2021","journal-title":"Turk. J. Biol."},{"key":"ref_79","first-page":"3194","article-title":"Natural products may interfere with SARS-CoV-2 attachment to the host cell","volume":"39","author":"Elfiky","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"e0164224","DOI":"10.1128\/jvi.01642-24","article-title":"Cathepsins in cellular entry of human pathogenic viruses","volume":"99","author":"Pathak","year":"2025","journal-title":"J. Virol."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Ulcakar, L., and Novinec, M. (2020). Inhibition of Human Cathepsins B and L by Caffeic Acid and Its Derivatives. Biomolecules, 11.","DOI":"10.3390\/biom11010031"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/17\/8\/1086\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:23:53Z","timestamp":1760034233000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/17\/8\/1086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,5]]},"references-count":81,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["v17081086"],"URL":"https:\/\/doi.org\/10.3390\/v17081086","relation":{},"ISSN":["1999-4915"],"issn-type":[{"type":"electronic","value":"1999-4915"}],"subject":[],"published":{"date-parts":[[2025,8,5]]}}}